FGF-1

DRUG2 trials

Sponsors

Venturis Therapeutics, Inc.

Conditions

Chronic WoundsDiabetesIntermittent ClaudicationPeripheral Arterial DiseaseStenosisVenous Stasis Ulcers

Phase 1

FGF-1 for Intramuscular Injection for the Treatment of Peripheral Arterial Disease

Not yet recruitingNCT00424866

Venturis Therapeutics, Inc.Intermittent Claudication, Peripheral Arterial Disease, Stenosis

Start: 2028-10-15End: 2030-12-15Target: 24Updated: 2026-08-19

FGF-1 for Topical Administration for the Treatment of Diabetic or Venous Stasis Ulcers

CompletedNCT00425178

Venturis Therapeutics, Inc.Chronic Wounds, Diabetes, Venous Stasis Ulcers

Start: 2005-09-02End: 2006-12-01Updated: 2026-08-19